Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parkin

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|January 20, 2011
In vitro characterization of GS-8374, a novel phosphonate-containing inhibitor of HIV-1 protease with a favorable resistance profileChristian Callebaut, Kirsten Stray, Luong Tsai, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Scientific Reports|February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testingEmma R Lee, Neil Parkin, Cheryl Jennings, et al.
Plos Medicine|January 18, 2007
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanismMonique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trialsEvguenia S Svarovskaia, Hadas Dvory-Sobol, Neil Parkin, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|January 20, 2011
In vitro characterization of GS-8374, a novel phosphonate-containing inhibitor of HIV-1 protease with a favorable resistance profileChristian Callebaut, Kirsten Stray, Luong Tsai, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Scientific Reports|February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testingEmma R Lee, Neil Parkin, Cheryl Jennings, et al.
Plos Medicine|January 18, 2007
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanismMonique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trialsEvguenia S Svarovskaia, Hadas Dvory-Sobol, Neil Parkin, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
Pageof 7